Article
Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.
Current oncology reports - 1 Apr 2015
Stover Daniel G, Wagle Nikhil
Abstract excerpt
Remarkable progress in sequencing technology over the past 20 years has made it possible to comprehensively profile tumors and identify clinically relevant genomic alterations. In breast cancer, the most common malignancy affecting women, we are now increasingly able to use this technology to help specify the use of therapies that target key molecular and genetic dependencies. Large sequencing studies have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
